The Types segment classifies services by methodological approach, each adding distinct value to the overall market. In vivo testing, performed on animal models, remains essential for evaluating systemic responses, mechanical integrity, and long‑term biocompatibility, representing the most resource‑intensive portion of the market. In vitro assays—such as cell culture cytotoxicity, corrosion, and wear simulations—provide high‑throughput screening and account for a significant share due to cost efficiency and regulatory acceptance. Ex vivo biomechanical testing, using harvested tissues, bridges the gap between in vitro and in vivo by offering realistic loading conditions while reducing animal use. Within these categories, sub‑services like mechanical fatigue testing, histopathological analysis, and surface characterization further diversify revenue streams. By dissecting the market into these methodological types, analysts can quantify how each contributes to total service volume and forecast shifts driven by ethical considerations, technological advances, and regulatory trends.